Summary
The effects of nimodipine and thyrotropin-releasing hormone (TRH) were compared in a clip-compression model of experimental spinal cord injuries (SCI) in rats. Thirty rats received a 50-g clip-compression injury on the cord at T9. Ten rats were given 0.02 mg/kg nimodipine and dextran 40 (3ml) i.v. 1h after injury. Ten rats were given 2 mg/kg TRH and dextran 40 (3ml) i.v. 1h after injury followed by 1 mg/kg per hour for 4h. The remaining ten rats were given only saline. TRH treatment significantly improved somatosensory-evoked potentials (SEPs) and mean arterial blood pressures (MABPs), whereas nimodipine treatment had no effect on these variables (Fisher's exact test (P<0.01).
Similar content being viewed by others
References
Anderson DK, Means ED (1983) Free radical induced lipid peroxidation in spinal cord. FeCl2 induction and protection with antioxidants. Neurochem Pathol 1:249–264
Anderson DK, Demediuk P, Saunders DR (1985) Spinal cord injury and protection. Ann Emerg Med 14:147–152
Black P, Markowitz RS, Finkelstein SD (1988) Experimental spinal cord injury: effects ofa calcium channel antagonist (nicardipine). Neurosurgery 22:61–66
Boyer CE, Cooper BR (1982) Thyrotropin releasing hormone in cat spinal cord: excitatory effects, regional distribution and effects of chronic spinal cord lesions. Fed Proc 41:1080
Ceylan S, Kalelioĝlu M, Aktürk G, Aktürk F, Ceylan S (1990) Medical treatment of acute spinal cord injuries. Res Exp Med 190:111–119
Collins WF (1983) A review and update of experimental and clinical studies of spinal cord injury. Paraplegia 21:204–219
Faden AI (1989) TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies. Brain Res 486:228–235
Faden AI, Jacobs TP (1985) Effect of TRH analogs on neurological recovery after experimental spinal trauma. Neurology 35:1331–1334
Faden AI, Jacobs TP, Smith MT (1984) Evaluation of the calcium channel antagonist nimodipine in experimental spinal cord ischemia. J Neurosurg 60:796–799
Faden AI, Jacobs TP, Smith MT (1984) Thyrotropin-releasing hormone in experimental spinal injury: dose response and late treatment. Neurology 34:1280–1284
Faden AI, Hill TG, Kuhek MJ (1986) Changes in TRH immunoreactivity in spinal cord after experimental spinal injury Neuropeptides 7:11–18
Faden AI, Pilotle NS, Burt DR (1986) Experimental spinal cord injury: effects of trauma or ischemia on TRH and muscarinic receptors. Neurology 36:723–726
Faden AI, Yum SW, Lemke M (1990) Effects of TRH-analog treatment on tissue cations, phospholipids and energy metabolism after spinal cord injury. J Pharmacol Exp Ther 255: 608–614
Fehlings MG, Tator CH, Linden RD (1989) The effect of nimodipine and dextran on axonal function and blood flow following experimental spinal cord injury. J Neurosurg 71: 403–416
Ford RW, Malm DN (1986) Failure of nimodipine to nerve acute experimental spinal cord injury. Cent Nerv Syst Trauma 2:9–17
Freedman J, Hokfelt T, Johnson G (1986) Thyrotropin-releasing hormone (TRH) counteracts neuronal damage induced by a substance P antagonist. Exp Brain Res 62:175–178
Gelmers HJ (1982) Effect of nimodipine (Bay e 9736) on postischaemic cerebro vascular reactivity as revealed by measuring regional cerebral blood flow (r CBF) Acta Neurochir 63:283–290
Griffiths IR (1976) Spinal cord blood flow after acute experimental cord injury in dogs. J Neurol Sci 27:247–259
Guha A, Tator CH, Piper I (1987) Effect of a calcium channel blocker on post-traumatic spinal cord blood flow. J Neurosurg 66:423–430
Hall ED, Wolf DL (1986) A pharmacological analysis of the pathophysiological mechanisms of post-traumatic spinal cord ischemia. J Neurosurg 64:951–961
Hashimoto T, Fukuda N (1990) Effect of thyrotropin-releasing hormone on the time course of neurologic recovery after spinal cord injury in the rat Japan. J Pharmacol 53:479–486
Hedeman LS, Ranajit S (1974) Studies in experimental spinal cord trauma. II. Comparison of treatment with steroids. Low molecular weight dextran and catecholamine blockade. J. Neurosurg 40:5–53
Hsu Cy, Halushka PV, Hogan EI (1983) Altered synthesis of thromboxane and prostacyclin in spinal cord contusion. Neurology 33 [Suppl] 2: 146
Kunhara M (1985) Role of monoamines in experimental spinal cord injury in rats. Relationship between Na+-K+-ATPase and lipid peroxidation. J Neurosurg 62:743–749
Lux WE, Feuertein G, Faden AI (1983) Alteration of leukotriene D4 hyptension by thyrotropin releasing hormone. Nature 10:301–307
Manaker S, Winokur A, Rhodes CH (1983) Autoradiographic localization of thyrotropinreleasing hormone (TRH) receptors in human spinal cord Neurology 35:328–332
Nayler WG (1982) Calcium antagonism: a new approach. Clin Exp Pharmacol Physiol [Suppl] 6: 3–13
Nicoll RA (1978) The action of thyrotropin releasing hormone, substance P and related peptides on frog spinal motorneurons. J Pharmacol Exp Ther 207:817–824
Saunders RD, Anderson DK, Horrocks LA (1980) Arachidonic acid and lipid metabolism following spinal cord trauma. Soc Neurosci Abs 10:998
Sharif NA, Pilotte NS, Burt DR (1983) Biochemical and autoradiographic studies of TRH receptors in sections of rabbit spinal cord. biochem Biophys Res Commun 116:669–674
Stokes BT, Fox P, Hollinden G (1983) Extracellular calcium activity in the injured spinal cord. Exp Neurol 80:561–572
Taylor RL, Burt DR (1982) Species differences in the brain regional distribution of receptor binding for thyrotropin releasing hormone. J Neurochem 38:1649–1656
Young W, Yen V, Blight A (1982) Extracellular calcium ionic activity in experimental spinal cord contusion. Brain Res 253:105–113
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ceylan, S., Ilbay, K., Baykal, S. et al. Treatment of acute spinal cord injuries: comparison of thyrotropin-releasing hormone and nimodipine. Res. Exp. Med. 192, 23–33 (1992). https://doi.org/10.1007/BF02576254
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02576254